STMN2 and amyotrophic lateral sclerosis: Extensive evidence points to expression of a cryptic exon in STMN2 transcripts that may account for some features of the phenotype observed in cell-based models of ALS, such as diminished axonal regenerative capacity (Klim et al., 2019; Melamed et al., 2019).